- Home
- Medical news & Guidelines
- Anesthesiology
- Cardiology and CTVS
- Critical Care
- Dentistry
- Dermatology
- Diabetes and Endocrinology
- ENT
- Gastroenterology
- Medicine
- Nephrology
- Neurology
- Obstretics-Gynaecology
- Oncology
- Ophthalmology
- Orthopaedics
- Pediatrics-Neonatology
- Psychiatry
- Pulmonology
- Radiology
- Surgery
- Urology
- Laboratory Medicine
- Diet
- Nursing
- Paramedical
- Physiotherapy
- Health news
- Fact Check
- Bone Health Fact Check
- Brain Health Fact Check
- Cancer Related Fact Check
- Child Care Fact Check
- Dental and oral health fact check
- Diabetes and metabolic health fact check
- Diet and Nutrition Fact Check
- Eye and ENT Care Fact Check
- Fitness fact check
- Gut health fact check
- Heart health fact check
- Kidney health fact check
- Medical education fact check
- Men's health fact check
- Respiratory fact check
- Skin and hair care fact check
- Vaccine and Immunization fact check
- Women's health fact check
- AYUSH
- State News
- Andaman and Nicobar Islands
- Andhra Pradesh
- Arunachal Pradesh
- Assam
- Bihar
- Chandigarh
- Chattisgarh
- Dadra and Nagar Haveli
- Daman and Diu
- Delhi
- Goa
- Gujarat
- Haryana
- Himachal Pradesh
- Jammu & Kashmir
- Jharkhand
- Karnataka
- Kerala
- Ladakh
- Lakshadweep
- Madhya Pradesh
- Maharashtra
- Manipur
- Meghalaya
- Mizoram
- Nagaland
- Odisha
- Puducherry
- Punjab
- Rajasthan
- Sikkim
- Tamil Nadu
- Telangana
- Tripura
- Uttar Pradesh
- Uttrakhand
- West Bengal
- Medical Education
- Industry
Ciprofol as effective as propofol among patients undergoing gynaecological surgery: study
Ciprofol is as effective as propofol in patients undergoing gynaecological surgery suggests a recent study published in the BMC Anesthesiology.
Ciprofol is a recently developed, short-acting γ-aminobutyric acid receptor agonist sedative that is more potent than propofol. Still, there have been few clinical studies of this agent to date. Here, we sought to examine the safety and efficacy of ciprofol use for the induction of general anaesthesia in individuals undergoing gynaecological surgery.
Women between the ages of 18 and 60 years (ASA physical status 1 or 2) who were scheduled to undergo elective gynaecological surgery under general anaesthesia were randomly assigned to two equally sized groups in which anaesthesia induction was performed using either ciprofol or propofol. General anaesthesia induction success rates were the primary outcome for this study, while secondary outcomes included changes in BIS during the 10 min following the first administration of the study drug, the duration of successful induction, and adverse event incidence.
The results of the study are:
- A total of 120 women were included in the study.
- A 100% rate of successful induction was achieved in both the ciprofol and propofol groups, with no significant differences between these groups with respect to the duration of successful induction, the time to the disappearance of the eyelash reflex or tracheal intubation
- Adverse event rates, including intubation responses, were significantly lower in the ciprofol group as compared to the propofol group
- Ciprofol was associated with reduced injection pain relative to propofol
Thus, Ciprofol exhibits comparable efficacy to that of propofol when used for the induction of general anaesthesia in individuals undergoing gynaecological surgery and is associated with fewer adverse events.
Reference:
Chen, Bz., Yin, Xy., Jiang, Lh. et al. The efficacy and safety of ciprofol use for the induction of general anaesthesia in patients undergoing gynaecological surgery: a prospective randomized controlled study. BMC Anesthesiol 22, 245 (2022). https://doi.org/10.1186/s12871-022-01782-7
Keywords:
Ciprofol, effective, propofol, patients, undergoing, gynaecological, surgery, BMC Anesthesiology, Ben-zhen Chen, Xin-yu Yin, Li-hua Jiang, Jin-hui Liu, Yan-yan Shi & Bi-ying Yuan
Dr. Shravani Dali has completed her BDS from Pravara institute of medical sciences, loni. Following which she extensively worked in the healthcare sector for 2+ years. She has been actively involved in writing blogs in field of health and wellness. Currently she is pursuing her Masters of public health-health administration from Tata institute of social sciences. She can be contacted at editorial@medicaldialogues.in.
Dr Kamal Kant Kohli-MBBS, DTCD- a chest specialist with more than 30 years of practice and a flair for writing clinical articles, Dr Kamal Kant Kohli joined Medical Dialogues as a Chief Editor of Medical News. Besides writing articles, as an editor, he proofreads and verifies all the medical content published on Medical Dialogues including those coming from journals, studies,medical conferences,guidelines etc. Email: drkohli@medicaldialogues.in. Contact no. 011-43720751